Search results
Results from the WOW.Com Content Network
Sinclair (SBGI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Sirtris Pharmaceuticals, Inc. was a biotechnology company based in Cambridge, MA that developed therapies for type 2 diabetes, cancer, and other diseases. Conceived in 2004 by Harvard University biologist David Sinclair and Andrew Perlman, [1] and founded that year by Sinclair and Perlman, along with Christoph Westphal, Richard Aldrich, Richard Pops, and Paul Schimmel, [2] the company was ...
Since stock splits don't impact the company's earnings or future prospects, they aren't catalysts for share price performance -- investors generally won't buy or sell a stock just because it ...
For premium support please call: 800-290-4726 more ways to reach us
In July 2018, it became the first cannabis company to trade publicly on a major U.S. stock exchange, [13] opening on the NASDAQ exchange at a price of $17 per share, which increased in September 2018 to $214 per share, and then descended to $29 per share by August 2019. [14] [15] The IPO raised US$153 million. [16]
A ticker symbol or stock symbol is an abbreviation used to uniquely identify publicly traded shares of a particular stock or security on a particular stock exchange. Ticker symbols are arrangements of symbols or characters (generally Latin letters or digits) which provide a shorthand for investors to refer to, purchase, and research securities.
For premium support please call: 800-290-4726 more ways to reach us
Chengdu Kanghong Pharmaceutical Group Co., Ltd. is a publicly traded pharmaceutical company based in the province of Sichuan, China. [1] It was founded in 1996 and researches, develops, manufactures, and distributes medicines [ 2 ] for ophthalmic , central nervous , digestive and endocrine systems. [ 1 ]